|
1
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abdalla EK, Bauer TW, Chun YS, D'Angelica
M, Kooby DA and Jarnagin WR: Locoregional surgical and
interventional therapies for advanced colorectal cancer liver
metastases: Expert consensus statements. HPB (Oxford). 15:119–130.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grothey A, Van Cutsem E, Sobrero A, Siena
S, Falcone A, Ychou M, Humblet Y, Bouché O, Mineur L, Barone C, et
al: Regorafenib monotherapy for previously treated metastatic
colorectal cancer (CORRECT): An international, multicentre,
randomised, placebo-controlled, phase 3 trial. Lancet. 381:303–312.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pritchard CC, Cheng HH and Tewari M:
MicroRNA profiling: Approaches and considerations. Nat Rev Genet.
13:358–369. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Friedman RC and Burge CB: MicroRNA target
finding by comparative genomics. Methods Mol Biol. 1097:457–476.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 9:8522017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schee K, Boye K, Abrahamsen TW, Fodstad Ø
and Flatmark K: Clinical relevance of microRNA miR-21, miR-31,
miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer. BMC
Cancer. 12:5052012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Faltejskova P, Svoboda M, Srutova K,
Mlcochova J, Besse A, Nekvindova J, Radova L, Fabian P, Slaba K,
Kiss I, et al: Identification and functional screening of microRNAs
highly deregulated in colorectal cancer. J Cell Mol Med.
16:2655–2666. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang L, Yang F, Yuan JH, Yuan SX, Zhou
WP, Huo XS, Xu D, Bi HS, Wang F and Sun SH: Epigenetic activation
of the MiR-200 family contributes to H19-mediated metastasis
suppression in hepatocellular carcinoma. Carcinogenesis.
34:577–586. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Toiyama Y, Hur K, Tanaka K, Inoue Y,
Kusunoki M, Boland CR and Goel A: Serum miR-200c is a novel
prognostic and metastasis-predictive biomarker in patients with
colorectal cancer. Ann Surg. 259:735–743. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hamilton SR, Bosman FT and Boffetta P:
Carcinoma of the colon and rectumWHO Classification of Tumours of
the Digestive System. Bosman FT, Carneiro F, Hruban RH and Theise
ND: Lyon: IARC Press; pp. 134–146. 2010
|
|
12
|
Kyrylkova K, Kyryachenko S, Leid M and
Kioussi C: Detection of apoptosis by TUNEL assay. Methods Mol Biol.
887:41–47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stevens P, An Wen Y, Li X and Gao T:
Erbin-mediated regulation of colon cancer. FASEB J. 29:724–726.
2015.PubMed/NCBI
|
|
14
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tamagawa S, Beder LB, Hotomi M, Gunduz M,
Yata K, Grenman R and Yamanaka N: Role of miR-200c/miR-141 in the
regulation of epithelial-mesenchymal transition and migration in
head and neck squamous cell carcinoma. Int J Mol Med. 33:879–886.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lynch SM, O'Neill KM, McKenna MM, Walsh CP
and McKenna DJ: Regulation of miR-200c and miR-141 by methylation
in prostate cancer. Prostate. 76:1146–1159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gibbons DL, Lin W, Creighton CJ, Rizvi ZH,
Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y,
Pertsemlidis A and Kurie JM: Contextual extracellular cues promote
tumor cell EMT and metastasis by regulating miR-200 family
expression. Genes Dev. 23:2140–2151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brabletz T: EMT and MET in metastasis:
Where are the cancer stem cells? Cancer Cell. 22:699–701. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu M, Marsters S, Ye X, Luis E, Gonzalez L
and Ashkenazi A: E-cadherin couples death receptors to the
cytoskeleton to regulate apoptosis. Mol Cell. 54:987–998. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu H, Shen Y, Hong J, Xia Q, Zhou F and
Liu X: The contribution of TGF-β in epithelial-mesenchymal
transition (EMT): down-regulation of E-cadherin via snail.
Neoplasma. 62:1–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
